Skip to main content

Table 2 Estimated 10-year cardiovascular risk among Chinese antiretroviral-naïve HIV-infected patients

From: Cardiovascular disease risk among Chinese antiretroviral-naïve adults with advanced HIV disease

Characteristics All n/N (%) Male n/N (%) Female n/N (%) p-value
FRS     NA
  < 10% 921/965 (95.5%) 671/715 (93.8%) 250/250 (100%)  
 10–20% 39/965 (4.0%) 39/715 (5.5%) 0/250 (0%)  
  > 20% 5/965 (0.5%) 5/715 (0.7%) 0/250 (0%)  
D:A:D Risk Score     NA
  < 10% 941/973 (96.7%) 692/722 (95.8%) 249/251 (99.2%)  
 10–20% 20/973 (2.1%) 18/722 (2.5%) 2/251 (0.8%)  
  > 20% 12 /973 (1.2%) 12/722 (1.7%) 0/251 (0%)  
Favorable Cardiovascular Risk Profile 364/973 (37.4%) 257/722 (35.6%) 107/251 (42.6%) 0.047
  1. NA, not applicable; FRS, the Framingham Risk Score; (D:A:D) Risk Score, Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores; Favorable cardiovascular risk profile was defined on the basis of a number of modifiable risk factors as follows: total cholesterol <5.17 mmol/l, systolic blood pressure ≤ 120 mmHg, diastolic blood pressure ≤ 80 mmHg, no current smoking, no diabetes and no prior CVD